Biphasic Production of Anti-ApoB100 Autoantibodies in Obese Humans and Mice
Obesity is associated with autoimmunity, a phenomenon considered as harmful. Here we show that obese mice and humans produce IgG-type autoantibodies that specifically recognize apolipoprotein B-100 (ApoB100), its native epitope p210, and the synthetic p210 mimotope pB1. By contrast, antibodies again...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-04-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/14/4/330 |
| _version_ | 1797538815124963328 |
|---|---|
| author | Moon Kyung Choe Hyung-Ji Kim Nan Hee Kim Bert Binas Hyo Joon Kim |
| author_facet | Moon Kyung Choe Hyung-Ji Kim Nan Hee Kim Bert Binas Hyo Joon Kim |
| author_sort | Moon Kyung Choe |
| collection | DOAJ |
| description | Obesity is associated with autoimmunity, a phenomenon considered as harmful. Here we show that obese mice and humans produce IgG-type autoantibodies that specifically recognize apolipoprotein B-100 (ApoB100), its native epitope p210, and the synthetic p210 mimotope pB1. By contrast, antibodies against epitopes p45 and p240, which have been associated with atherosclerosis, were not detected in either the humans or mice. In a longitudinal analysis of high fat diet-fed mice, autoantibody production rose with increasing body weight, then decreased and plateaued at morbid obesity. Likewise, in a cross-sectional analysis of sera from 148 human volunteers spanning a wide BMI range and free of comorbidities, the immunoreactivity increased and then decreased with increasing BMI. Thus, the obesity-related ApoB100-specific natural autoantibodies characteristically showed the same epitope recognition, IgG-type, and biphasic serum levels in humans and mice. We previously reported that a pB1-based vaccine induces similar antibodies and can prevent obesity in mice. Therefore, our present results suggest that autoantibodies directed against native ApoB100 may mitigate obesity, and that the vaccination approach may be effective in humans. |
| first_indexed | 2024-03-10T12:36:46Z |
| format | Article |
| id | doaj.art-7fecd46264344e678cef54fa35d316f6 |
| institution | Directory Open Access Journal |
| issn | 1424-8247 |
| language | English |
| last_indexed | 2024-03-10T12:36:46Z |
| publishDate | 2021-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmaceuticals |
| spelling | doaj.art-7fecd46264344e678cef54fa35d316f62023-11-21T14:13:26ZengMDPI AGPharmaceuticals1424-82472021-04-0114433010.3390/ph14040330Biphasic Production of Anti-ApoB100 Autoantibodies in Obese Humans and MiceMoon Kyung Choe0Hyung-Ji Kim1Nan Hee Kim2Bert Binas3Hyo Joon Kim4Department of Molecular & Life Science, College of Science & Technology, Hanyang University (ERICA), 55 Hanyangdaehak-ro, Sangnok-gu, Ansan, Gyeonggi-do 15588, KoreaAsan Medical Center, Department of Neurology, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, KoreaDepartment of Internal Medicine, Division of Endocrinology and Metabolism, College of Medicine, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, KoreaDepartment of Molecular & Life Science, College of Science & Technology, Hanyang University (ERICA), 55 Hanyangdaehak-ro, Sangnok-gu, Ansan, Gyeonggi-do 15588, KoreaDepartment of Molecular & Life Science, College of Science & Technology, Hanyang University (ERICA), 55 Hanyangdaehak-ro, Sangnok-gu, Ansan, Gyeonggi-do 15588, KoreaObesity is associated with autoimmunity, a phenomenon considered as harmful. Here we show that obese mice and humans produce IgG-type autoantibodies that specifically recognize apolipoprotein B-100 (ApoB100), its native epitope p210, and the synthetic p210 mimotope pB1. By contrast, antibodies against epitopes p45 and p240, which have been associated with atherosclerosis, were not detected in either the humans or mice. In a longitudinal analysis of high fat diet-fed mice, autoantibody production rose with increasing body weight, then decreased and plateaued at morbid obesity. Likewise, in a cross-sectional analysis of sera from 148 human volunteers spanning a wide BMI range and free of comorbidities, the immunoreactivity increased and then decreased with increasing BMI. Thus, the obesity-related ApoB100-specific natural autoantibodies characteristically showed the same epitope recognition, IgG-type, and biphasic serum levels in humans and mice. We previously reported that a pB1-based vaccine induces similar antibodies and can prevent obesity in mice. Therefore, our present results suggest that autoantibodies directed against native ApoB100 may mitigate obesity, and that the vaccination approach may be effective in humans.https://www.mdpi.com/1424-8247/14/4/330obese patientsapolipoprotein B-100IgG-type autoantibodyhigh-fat diet induced obesityepitopemimotope |
| spellingShingle | Moon Kyung Choe Hyung-Ji Kim Nan Hee Kim Bert Binas Hyo Joon Kim Biphasic Production of Anti-ApoB100 Autoantibodies in Obese Humans and Mice Pharmaceuticals obese patients apolipoprotein B-100 IgG-type autoantibody high-fat diet induced obesity epitope mimotope |
| title | Biphasic Production of Anti-ApoB100 Autoantibodies in Obese Humans and Mice |
| title_full | Biphasic Production of Anti-ApoB100 Autoantibodies in Obese Humans and Mice |
| title_fullStr | Biphasic Production of Anti-ApoB100 Autoantibodies in Obese Humans and Mice |
| title_full_unstemmed | Biphasic Production of Anti-ApoB100 Autoantibodies in Obese Humans and Mice |
| title_short | Biphasic Production of Anti-ApoB100 Autoantibodies in Obese Humans and Mice |
| title_sort | biphasic production of anti apob100 autoantibodies in obese humans and mice |
| topic | obese patients apolipoprotein B-100 IgG-type autoantibody high-fat diet induced obesity epitope mimotope |
| url | https://www.mdpi.com/1424-8247/14/4/330 |
| work_keys_str_mv | AT moonkyungchoe biphasicproductionofantiapob100autoantibodiesinobesehumansandmice AT hyungjikim biphasicproductionofantiapob100autoantibodiesinobesehumansandmice AT nanheekim biphasicproductionofantiapob100autoantibodiesinobesehumansandmice AT bertbinas biphasicproductionofantiapob100autoantibodiesinobesehumansandmice AT hyojoonkim biphasicproductionofantiapob100autoantibodiesinobesehumansandmice |